Establishment of a New Hyperglycemic Obesity Cardiac Dysfunction Mouse Model with Triacsin C

Objective This study aims to establish a novel hyperglycemic obesity mouse model by utilizing Triacsin C, an inhibitor of acyl-CoA synthetase long-chain family member 1 (ACSL1), combined with a high-fat diet, to simulate the changes in adipose tissue and cardiac function observed in patients with ob...

Full description

Saved in:
Bibliographic Details
Main Authors: ZHAO Xiaona, WANG Peng, YE Maoqing, QU Xinkai
Format: Article
Language:zho
Published: Editorial Office of Laboratory Animal and Comparative Medicine 2024-12-01
Series:Shiyan dongwu yu bijiao yixue
Subjects:
Online Access:https://www.slarc.org.cn/dwyx/CN/10.12300/j.issn.1674-5817.2024.078
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841558871910383616
author ZHAO Xiaona
WANG Peng
YE Maoqing
QU Xinkai
author_facet ZHAO Xiaona
WANG Peng
YE Maoqing
QU Xinkai
author_sort ZHAO Xiaona
collection DOAJ
description Objective This study aims to establish a novel hyperglycemic obesity mouse model by utilizing Triacsin C, an inhibitor of acyl-CoA synthetase long-chain family member 1 (ACSL1), combined with a high-fat diet, to simulate the changes in adipose tissue and cardiac function observed in patients with obesity-related type 2 diabetes.MethodsTwenty adult SPF-grade male C57BL/6J mice were randomly divided into two groups: the Control group (injected intraperitoneally with citric acid-sodium citrate buffer, Con group) and the TC group (injected intraperitoneally with Triacsin C, TC group). After four consecutive weeks of intraperitoneal injections, both groups were fed high-fat diets. Body weight and glucose tolerance of the mice were assessed every eight weeks. The models were considered successful if fasting blood glucose exceeded 8 mmol/L or blood glucose was above 15 mmol/L two hours after glucose injection. Cardiac function, including ventricular end-diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), end-diastolic interventricular septal thickness (EDIVS), left ventricular ejection fraction (LVEF), and left ventricular short-axis fractional shortening (FS), was measured by echocardiography. HE staining was used to detect the changes in epididymal white adipose tissue (WAT) and brown adipose tissue (BAT). Immunofluorescence technology was used to analyze changes in CD31 and UCP1 in BAT. ACSL1 expression in myocardial tissue was tested by Western blotting.ResultsThe fasting blood glucose levels were (8.14±1.43) mmol/L in the Con group and (8.18±0.85) mmol/L in the TC group (P>0.05) , and the 2-hour postprandial blood glucose levels were (19.8±4.01) mmol/L in the Con group and (22.60±3.97) mmol/L in the TC group (P<0.05). This indicated that both groups of diabetic mouse models were successfully established. Compared to the Con group, the TC group showed poor glucose tolerance; significant decreases in LVEDD, LVEF and FS (P<0.05); significant increases in WAT and BAT areas (P<0.05); significant decreases in CD31 and UCP1 expression (P<0.05); and a significant decrease in the expression of ACSL1 in myocardial tissues (P<0.05).ConclusionCompared with the high-fat diet-induced type 2 diabetes model, the new hyperglycemic obesity and cardiac dysfunction mouse model, created by the combination of Triacsin C and a high-fat diet, is feasible and allows for easier observation of brown adipose tissue whitening, insulin resistance and cardiac dysfunction.
format Article
id doaj-art-d182f3ea02d441788283fa0e6fb292d3
institution Kabale University
issn 1674-5817
language zho
publishDate 2024-12-01
publisher Editorial Office of Laboratory Animal and Comparative Medicine
record_format Article
series Shiyan dongwu yu bijiao yixue
spelling doaj-art-d182f3ea02d441788283fa0e6fb292d32025-01-06T05:12:09ZzhoEditorial Office of Laboratory Animal and Comparative MedicineShiyan dongwu yu bijiao yixue1674-58172024-12-0144660561210.12300/j.issn.1674-5817.2024.0781674-5817(2024)06-0605-08Establishment of a New Hyperglycemic Obesity Cardiac Dysfunction Mouse Model with Triacsin CZHAO Xiaona0WANG Peng1YE Maoqing2QU Xinkai3Department of Cardiology, Huadong Hospital, Fudan University, Shanghai200040, ChinaDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai200032, ChinaShanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai200040, ChinaDepartment of Cardiology, Huadong Hospital, Fudan University, Shanghai200040, ChinaObjective This study aims to establish a novel hyperglycemic obesity mouse model by utilizing Triacsin C, an inhibitor of acyl-CoA synthetase long-chain family member 1 (ACSL1), combined with a high-fat diet, to simulate the changes in adipose tissue and cardiac function observed in patients with obesity-related type 2 diabetes.MethodsTwenty adult SPF-grade male C57BL/6J mice were randomly divided into two groups: the Control group (injected intraperitoneally with citric acid-sodium citrate buffer, Con group) and the TC group (injected intraperitoneally with Triacsin C, TC group). After four consecutive weeks of intraperitoneal injections, both groups were fed high-fat diets. Body weight and glucose tolerance of the mice were assessed every eight weeks. The models were considered successful if fasting blood glucose exceeded 8 mmol/L or blood glucose was above 15 mmol/L two hours after glucose injection. Cardiac function, including ventricular end-diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), end-diastolic interventricular septal thickness (EDIVS), left ventricular ejection fraction (LVEF), and left ventricular short-axis fractional shortening (FS), was measured by echocardiography. HE staining was used to detect the changes in epididymal white adipose tissue (WAT) and brown adipose tissue (BAT). Immunofluorescence technology was used to analyze changes in CD31 and UCP1 in BAT. ACSL1 expression in myocardial tissue was tested by Western blotting.ResultsThe fasting blood glucose levels were (8.14±1.43) mmol/L in the Con group and (8.18±0.85) mmol/L in the TC group (P>0.05) , and the 2-hour postprandial blood glucose levels were (19.8±4.01) mmol/L in the Con group and (22.60±3.97) mmol/L in the TC group (P<0.05). This indicated that both groups of diabetic mouse models were successfully established. Compared to the Con group, the TC group showed poor glucose tolerance; significant decreases in LVEDD, LVEF and FS (P<0.05); significant increases in WAT and BAT areas (P<0.05); significant decreases in CD31 and UCP1 expression (P<0.05); and a significant decrease in the expression of ACSL1 in myocardial tissues (P<0.05).ConclusionCompared with the high-fat diet-induced type 2 diabetes model, the new hyperglycemic obesity and cardiac dysfunction mouse model, created by the combination of Triacsin C and a high-fat diet, is feasible and allows for easier observation of brown adipose tissue whitening, insulin resistance and cardiac dysfunction.https://www.slarc.org.cn/dwyx/CN/10.12300/j.issn.1674-5817.2024.078animal modelacyl-coa synthetase long-chain family member 1brown adipose tissuecardiac dysfunctionmice
spellingShingle ZHAO Xiaona
WANG Peng
YE Maoqing
QU Xinkai
Establishment of a New Hyperglycemic Obesity Cardiac Dysfunction Mouse Model with Triacsin C
Shiyan dongwu yu bijiao yixue
animal model
acyl-coa synthetase long-chain family member 1
brown adipose tissue
cardiac dysfunction
mice
title Establishment of a New Hyperglycemic Obesity Cardiac Dysfunction Mouse Model with Triacsin C
title_full Establishment of a New Hyperglycemic Obesity Cardiac Dysfunction Mouse Model with Triacsin C
title_fullStr Establishment of a New Hyperglycemic Obesity Cardiac Dysfunction Mouse Model with Triacsin C
title_full_unstemmed Establishment of a New Hyperglycemic Obesity Cardiac Dysfunction Mouse Model with Triacsin C
title_short Establishment of a New Hyperglycemic Obesity Cardiac Dysfunction Mouse Model with Triacsin C
title_sort establishment of a new hyperglycemic obesity cardiac dysfunction mouse model with triacsin c
topic animal model
acyl-coa synthetase long-chain family member 1
brown adipose tissue
cardiac dysfunction
mice
url https://www.slarc.org.cn/dwyx/CN/10.12300/j.issn.1674-5817.2024.078
work_keys_str_mv AT zhaoxiaona establishmentofanewhyperglycemicobesitycardiacdysfunctionmousemodelwithtriacsinc
AT wangpeng establishmentofanewhyperglycemicobesitycardiacdysfunctionmousemodelwithtriacsinc
AT yemaoqing establishmentofanewhyperglycemicobesitycardiacdysfunctionmousemodelwithtriacsinc
AT quxinkai establishmentofanewhyperglycemicobesitycardiacdysfunctionmousemodelwithtriacsinc